智通财经APP讯,康方生物(09926)发布公告,于2023年9月6日,公司已根据购股权计划向六名承授人授出45万份购股权,须待承授人接纳后,方告作实。授出的购股权行使价为35.08港元。
特别声明:以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布,本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.